Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:06 AM
Ignite Modification Date:
2025-12-25 @ 12:06 AM
NCT ID:
NCT05434858
Eligibility Criteria:
Inclusion Criteria:
* Serum urate level ≥ 80 mg/L on inclusion,
* No current or previous clinical symptoms of gout (including clinically apparent flares or tophus),
* Between 18 and 80 years old,
* Able to give informed consent.
Exclusion Criteria:
* GFR (glomerular filtration rate) \<30 ml / min / 1.73 m² or dialysis,
* Serious illness with a poor prognosis of less than 5 years,
* Autoimmune inflammatory arthritis,
* Change of geographical area within 5 years,
* Previous analysis of synovial fluid showing crystals of MSU,
* Presence of subcutaneous tophi,
* Taking a hypouricaemic treatment (allopurinol, probenecid, benzbromarone, febuxostat, lesinurad), canakinumab, anakinra or colchicine,
* Uricemia observed only after an acute decompensation of comorbidity
* Pregnant or breastfeeding women
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
80 Years
Study:
NCT05434858
Study Brief:
Protocol Section:
NCT05434858